Co-ordinatorUpdated: Jan 22, 2021
Ethical commitee approvals have been acheived for the study in Norway and Denmark
The consortium is now planning to start the First In Man study in Q2 2021
More updates to follow
The first patients have been enrolled in our clinical pilot study to evaluate the performance of the temporary epicardial pace wire with integrated sensor, CardiaSense CS1, for continuous postoperativ
We are happy to announce that approvals have now been granted from both Norwegian and Danish competent authorities (Statens Legemiddelverk and Lægemiddelstyrelsen) for the SAMBAfun clinical study "A m